| # | Drug | Count |
|---|---|---|
| 0 | AZATHIOPRINE | 8 |
| 1 | CAPLACIZUMAB | 8 |
| 2 | CYCLOSPORINE | 8 |
| 3 | RITUXIMAB | 8 |
| 4 | PREDNISOLONE | 4 |
| 5 | PREDNISOLONE ORAL | 4 |
| 6 | PREDNISOLONE ORAL SOLUTION | 4 |
| 7 | ACETAMINOPHEN | 1 |
| 8 | ACETAMINOPHEN 500MG | 1 |
| 9 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAPLACIZUMAB | 8 | 0.0045 |
| 1 | AZATHIOPRINE | 8 | 0.0001 |
| 2 | REMDESIVIR | 1 | 0.0001 |
| 3 | CYCLOSPORINE | 8 | 0.0001 |
| 4 | RITUXIMAB | 8 | 0.0000 |
| 5 | TAPENTADOL HYDROCHLORIDE | 1 | 0.0000 |
| 6 | PREDNISOLONE ORAL SOLUTION | 4 | 0.0000 |
| 7 | DOCUSATE SODIUM | 1 | 0.0000 |
| 8 | FENTANYL | 1 | 0.0000 |
| 9 | TOCILIZUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Purine Antimetabolite [EPC] | 8 | 0.0001 |
| 1 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 2 | Calcineurin Inhibitor Immunosuppressant [EPC] | 8 | 0.0001 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 8 | 0.0000 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | Corticosteroid [EPC] | 5 | 0.0000 |
| 6 | Opioid Agonist [EPC] | 1 | 0.0000 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |